Literature DB >> 16025137

Cirrhotic cardiomyopathy: an endocannabinoid connection?

Pál Pacher1, Sándor Bátkai, George Kunos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16025137      PMCID： PMC1576282          DOI： 10.1038/sj.bjp.0706332

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  12 in total

Review 1.  Cirrhotic cardiomyopathy: getting to the heart of the matter.

Authors:  Z Ma; S S Lee
Journal:  Hepatology       Date:  1996-08       Impact factor: 17.425

2.  Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors.

Authors:  M Domenicali; J Ros; G Fernández-Varo; P Cejudo-Martín; M Crespo; M Morales-Ruiz; A M Briones; J-M Campistol; V Arroyo; E Vila; J Rodés; W Jiménez
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

3.  Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis.

Authors:  S Bátkai; Z Járai; J A Wagner; S K Goparaju; K Varga; J Liu; L Wang; F Mirshahi; A D Khanolkar; A Makriyannis; R Urbaschek; N Garcia; A J Sanyal; G Kunos
Journal:  Nat Med       Date:  2001-07       Impact factor: 53.440

Review 4.  Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease.

Authors:  S Møller; J H Henriksen
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

5.  Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages.

Authors:  V Di Marzo; T Bisogno; L De Petrocellis; D Melck; P Orlando; J A Wagner; G Kunos
Journal:  Eur J Biochem       Date:  1999-08

6.  Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat.

Authors:  Josefa Ros; Joan Clària; Jordi To-Figueras; Anna Planagumà; Pilar Cejudo-Martín; Guillermo Fernández-Varo; Raúl Martín-Ruiz; Vicente Arroyo; Francisca Rivera; Juan Rodés; Wladmiro Jiménez
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

Review 7.  Blood pressure regulation by endocannabinoids and their receptors.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Neuropharmacology       Date:  2005-02-19       Impact factor: 5.250

8.  Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension.

Authors:  Sándor Bátkai; Pál Pacher; Douglas Osei-Hyiaman; Svetlana Radaeva; Jie Liu; Judith Harvey-White; László Offertáler; Ken Mackie; M Audrey Rudd; Richard D Bukoski; George Kunos
Journal:  Circulation       Date:  2004-09-27       Impact factor: 29.690

9.  Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor.

Authors:  Jie Liu; Sándor Batkai; Pál Pacher; Judith Harvey-White; Jens A Wagner; Benjamin F Cravatt; Bin Gao; George Kunos
Journal:  J Biol Chem       Date:  2003-08-29       Impact factor: 5.157

10.  Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle.

Authors:  Andreas Bonz; Martin Laser; Sina Küllmer; Silke Kniesch; Jörg Babin-Ebell; Verena Popp; Georg Ertl; Jens Andreas Wagner
Journal:  J Cardiovasc Pharmacol       Date:  2003-04       Impact factor: 3.105
View more
  7 in total

Review 1.  Cardiohepatic syndrome.

Authors:  Gerhard Poelzl; Johann Auer
Journal:  Curr Heart Fail Rep       Date:  2015-02

Review 2.  Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning.

Authors:  P Pacher; G Haskó
Journal:  Br J Pharmacol       Date:  2007-11-19       Impact factor: 8.739

3.  Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis.

Authors:  Mohanraj Rajesh; Hao Pan; Partha Mukhopadhyay; Sándor Bátkai; Douglas Osei-Hyiaman; György Haskó; Lucas Liaudet; Bin Gao; Pál Pacher
Journal:  J Leukoc Biol       Date:  2007-07-25       Impact factor: 4.962

Review 4.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

5.  Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury.

Authors:  Sándor Bátkai; Douglas Osei-Hyiaman; Hao Pan; Osama El-Assal; Mohanraj Rajesh; Partha Mukhopadhyay; Feng Hong; Judith Harvey-White; Anjum Jafri; György Haskó; John W Huffman; Bin Gao; George Kunos; Pál Pacher
Journal:  FASEB J       Date:  2007-02-27       Impact factor: 5.191

6.  Interplay of Liver-Heart Inflammatory Axis and Cannabinoid 2 Receptor Signaling in an Experimental Model of Hepatic Cardiomyopathy.

Authors:  Csaba Matyas; Katalin Erdelyi; Eszter Trojnar; Suxian Zhao; Zoltan V Varga; Janos Paloczi; Partha Mukhopadhyay; Balazs T Nemeth; György Haskó; Resat Cinar; Robim M Rodrigues; Yeni Ait Ahmed; Bin Gao; Pal Pacher
Journal:  Hepatology       Date:  2020-01-24       Impact factor: 17.298

Review 7.  Cirrhotic cardiomyopathy.

Authors:  Soon Koo Baik; Tamer R Fouad; Samuel S Lee
Journal:  Orphanet J Rare Dis       Date:  2007-03-27       Impact factor: 4.123
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.